Novo's Ozempic, Wegovy picked for US Medicare price negotiations
Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for Medicare price negotiations for 2027, the U.S. government said on Friday, part of a law pharmaceutical companies have pledged to revisit with the Trump administration.
Stock prices for Novo Nordisk fell by about 3% at market open after the Biden administration selected its revolutionary drugs ...
El Lilly’s blockbuster weight-loss drug Zepbound is now eligible for coverage under Medicare prescription drug plans, when ...
Medicare Part D plans can only cover obesity ... Lilly and its main rival in the obesity-drug race, Denmark's Novo Nordisk (NVO) (DK:NOVO.B), are conducting trials to evaluate GLP-1 drugs as ...
Ozempic, Wegovy and other new drugs are selected for Medicare's price negotiations - The Biden administration says popular ...
As Trump attempts to come to terms with the transition from campaign mode to serving in government, three areas of tension ...
Trump said he got Mexico to agree to stop migration through Mexico. Trump claims his influence caused the Israel-Hezbollah truce, that he got Canada to stop the U.S. opioid crisis and that he caused ...
If Donald Trump seizes the Panama Canal, Greenland and Canada, perhaps Glenn Youngkin should go after West Virginia.
essanews.com on MSN3h
Trump's billionaire cabinet and 'Vice President Musk' unveiledThirteen billionaires and ten individuals from television or the entertainment industry will be part of Donald Trump's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback